In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report), with a price target of $11.00. The company's shares closed last Tuesday at $3.19. According to TipRanks.com, Chen has 0 stars on 0-5 stars ranking scale with an average return of -11.8% and a 31.7% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Anixa Biosciences with a $11.00 average price target.
https://www.tipranks.com/news/blurbs/h-c-wainwright-reiterates-their-buy-rating-on-anixa-biosciences-anix?utm_source=advfn.com&utm_medium=referral